Raidium was founded by Paul Herent, M.D., Msc, Paul Hérent, Pierre Manceron in 2022.

Who are Raidium's investors?

Raidium's investors include Galion.exe, Kurma Partners, Newfund Capital, Founders Future, Debiopharm Innovation Fund, StartX.

Where is Raidium headquartered?

Raidium is headquartered in Paris, FR.

Raidium

Paris, FR · Founded 2022 · 53 employees on LinkedIn · 8 known investors

Find your way into Raidium

534 people in our graph share verified history with the Raidium team — schools, employers, funds. One of them is your warm intro.

Shardul Shahunlockedknows Pierre Manceron · together at Datadog (overlapped)

knows the team · via CentraleSupélec

knows the team · via The Galion Project

×3knows the team · via StartX

×2knows the team · via Datadog

×3knows the team · via Université Paris Cité

Raidium builds an AI-native PACS viewer embedding a vision-language foundation model to support radiologists across research and clinical work, including automated tumor measurement and lesion segmentation. The company serves radiologists and medical/academic imaging research teams, and is based in France.

AI & Machine Learning Digital Health Medical Devices

Founders & leadership

Raidium was founded in 2022 by Paul Herent, M.D., Msc, Paul Hérent, and Pierre Manceron.

Paul Herent, M.D., Msc inco-founder, CEOPaul Herent is a radiologist with a background in cognitive science and machine learning applications in healthcare. He worked on AI research projects at Owkin Lab from 2018 to 2022 before co-founding Raidium in 2022.

Paul Hérent inCo-Founder and CEOPaul Hérent is a radiologist with a background in cognitive science who worked on AI research applications in healthcare at Owkin Lab from 2018 to 2022, before co-founding Raidium in 2022 with fellow ML engineer Pierre Manceron.

Pierre Manceron inCo-Founder and CSOPierre Manceron studied applied mathematics and machine learning at Centrale Paris and ENS Cachan, and previously conducted medical research at Owkin. He is co-founder and Chief Science Officer of Raidium, which develops an AI-native PACS viewer with vision-language models for radiologists.

Sebastian SchwarzinCOO

Damien BenardinCFO

Investors · 8

Galion.exe✓ verified$275K – $2.8M

Kurma Partners✓ verifiedParis · $162K – $10.8M

Newfund Capital✓ verifiedParis · $250K – $2M

Founders Future✓ verifiedParis

Debiopharm Innovation FundLausanne · $1M – $5M

StartXreportedPalo Alto · $10K – $1M

Also in the syndicate · 2

European EIC fundKurmalead

Funding

SEC filings, press & company announcements

Undisclosed amountSeedDec 2024
Kurma (lead), Newfund (lead), European EIC fund, Founders Future, Galion.exe
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

French startup Raidium secures $13M Seed for precision radiology - Tech.eutech.eu · Dec 2024

Startup Raidium raises nearly $17M, seeks to launch the ‘GPT of radiology’radiologybusiness.com · Dec 2024

Frequently asked questions

What does Raidium do?: Raidium builds an AI-native PACS viewer embedding a vision-language foundation model to support radiologists across research and clinical work, including automated tumor measurement and lesion segmentation. The company serves radiologists and medical/academic imaging research teams, and is based in France.
Who founded Raidium?: Raidium was founded by Paul Herent, M.D., Msc, Paul Hérent, Pierre Manceron in 2022.
Who are Raidium's investors?: Raidium's investors include Galion.exe, Kurma Partners, Newfund Capital, Founders Future, Debiopharm Innovation Fund, StartX.
Where is Raidium headquartered?: Raidium is headquartered in Paris, FR.